Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

被引:62
作者
Radfar, Seyed Ramin [1 ,2 ]
De Jong, Cornelis A. J. [3 ]
Farhoudian, Ali [4 ]
Ebrahimi, Mohsen [5 ,6 ]
Rafei, Parnian [7 ]
Vahidi, Mehrnoosh [4 ]
Yunesian, Masud [8 ]
Kouimtsidis, Christos [9 ]
Arunogiri, Shalini [10 ]
Massah, Omid [11 ]
Deylamizadeh, Abbas [12 ]
Brady, Kathleen T. [13 ]
Busse, Anja [14 ]
Potenza, Marc N. [15 ]
Ekhtiari, Hamed [16 ,17 ]
Baldacchino, Alexander Mario [18 ]
机构
[1] Univ Tehran Med Sci, Sch Adv Technol Med SATiM, Dept Neurosci & Addict, Tehran, Iran
[2] Univ Calif Los Angeles, Integrated Subst Abuse Programs Dept, Los Angeles, CA USA
[3] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands
[4] Univ Tehran Med Sci, Dept Psychiat, Tehran, Iran
[5] Mat & Energy Res Ctr, Tehran, Iran
[6] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Tehran, Iran
[7] Univ Tehran, Fac Psychol & Educ, Dept Psychol, Tehran, Iran
[8] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran
[9] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England
[10] Eastern Hlth, Turning Point, Box Hill, Vic, Australia
[11] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran
[12] Rebirth Char Soc NGO, Tehran, Iran
[13] Med Univ South Carolina, Charleston, SC 29425 USA
[14] United Nations Off Drugs & Crime, Drug Prevent & Hlth Branch, Div Operat, Prevent Treatment & Rehabil Sect, Vienna, Austria
[15] Yale Sch Med, Connecticut Council Problem Gambling, New Haven, CT USA
[16] Yale Sch Med, Connecticut Mental Hlth Ctr, New Haven, CT USA
[17] Laureate Inst Brain Res, Tulsa, OK USA
[18] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
关键词
COVID-19; pandemic; substance use disorder; public health; drug policy; opioid agonist treatment; addiction services; harm reduction; CLIMATE-CHANGE; USE DISORDER; PEOPLE; VULNERABILITY; IMMUNITY; STRESS; IMPACT;
D O I
10.3389/fpsyt.2021.639393
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives
    Austin, Elizabeth J.
    Corcorran, Maria A.
    Briggs, Elsa S.
    Frost, Madeline C.
    Behrends, Czarina N.
    Juarez, Alexa M.
    Frank, Noah D.
    Healy, Elise
    Prohaska, Stephanie M.
    LaKosky, Paul A.
    Kapadiadd, Shashi N.
    Perlman, David C.
    Schackman, Bruce R.
    Des Jarlais, Don C.
    Williams, Emily C.
    Glick, Sara N.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 109
  • [32] Stress and parenting during the global COVID-19 pandemic
    Brown, Samantha M.
    Doom, Jenalee R.
    Lechuga-Pena, Stephanie
    Watamura, Sarah Enos
    Koppels, Tiffany
    CHILD ABUSE & NEGLECT, 2020, 110
  • [33] Global syndicated lending during the COVID-19 pandemic
    Hasan, Iftekhar
    Politsidis, Panagiotis N.
    Sharma, Zenu
    JOURNAL OF BANKING & FINANCE, 2021, 133
  • [34] Use of telehealth mental health services during the COVID-19 pandemic
    Jayawardana, Danusha
    Gannon, Brenda
    AUSTRALIAN HEALTH REVIEW, 2021, 45 (04) : 442 - 446
  • [35] Changes in Opioid Treatment Programs and Harm Reduction Provider Services During the COVID-19 Pandemic: Findings From 10 States
    Heidari, Omeid
    Shah, Hridika
    Bhagwat, Atharva
    Ahmad, N. Jia
    Whaley, Sara
    Sherman, Susan G.
    Morris, Miles
    Saloner, Brendan
    PSYCHOLOGICAL SERVICES, 2024, 21 (03) : 658 - 664
  • [36] At the Intersection of Harm Reduction and COVID-19: The Role of Anthropologists during and Post-Pandemic
    Harris, Shana
    Schlosser, Allison
    HUMAN ORGANIZATION, 2021, 80 (04) : 272 - 281
  • [37] Research on substance use disorders during the COVID-19 pandemic
    Volkow, Nora D.
    Blanco, Carlos
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 129
  • [38] Hospitalizations after substance use during the COVID-19 pandemic
    Dumoulin, Claire
    Ong, Nathalie
    Ramaroson, Hanta
    Letinier, Louis
    Miremont-Salame, Ghada
    Gilleron, Veronique
    Daveluy, Amelie
    Perino, Justine
    THERAPIE, 2023, 78 (03): : 334 - 338
  • [39] Evaluation of substance use in Izmir during the COVID-19 pandemic
    Aydogdu, Melike
    Aslan, Rukiye
    Can, Ozge
    Altunci, Yusuf Ali
    Akgur, Serap Annette
    JOURNAL OF SUBSTANCE USE, 2022, 27 (06) : 629 - 635
  • [40] Reduction in healthcare services during the COVID-19 pandemic in China
    Zhang, Yi-Na
    Chen, Yun
    Wang, Ying
    Li, Fan
    Pender, Michelle
    Wang, Na
    Yan, Fei
    Ying, Xiao-Hua
    Tang, Sheng-Lan
    Fu, Chao-Wei
    BMJ GLOBAL HEALTH, 2020, 5 (11):